Algorithms Using Noninvasive Tests Can Accurately Identify Patients With Advanced Fibrosis Due to NASH: Data From the STELLAR Clinical Trials

Conference Reports for NATAP

The Liver Meeting
San Francisco
November 2018


Algorithms Using Noninvasive Tests Can Accurately Identify Patients With Advanced Fibrosis Due to NASH: Data From the STELLAR Clinical Trials

	Reported by Jules Levin AASLD 2018 Nov 9-13 SF AASLD: Routinely Available Noninvasive Tests Discriminate Advanced Fibrosis Due to NASH in the Phase 3 STELLAR Trials of the ASK1 Inhibitor Selonsertib - (11/16/18)